Warning: Undefined array key "article" in /home/askat/askat-inc.com/public_html/wp-content/themes/askat/single-news.php on line 27
Autoimmune disease Use Patent for EP4 antagonist Approved in Mexico|News | AskAt, Inc.

nemu

HOME　>　NEWS

NEWS

Autoimmune disease Use Patent for EP4 antagonist Approved in Mexico

2016/06/03

AskAt received a notice of allowance dated June 3, 2016 from the Instituto Mexicano de la Propiedad Industrial (IMPI) in connection with the Application No. Mx/a/2012/009503, a use patent of EP4 antagonist.

PAGE TOP

Menu